Market Overview:
The global prefillable inhaler market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, rising demand for technologically advanced products, and growing awareness about asthma and other respiratory diseases. Based on type, the liquid drug prefillable inhaler segment is expected to account for the largest share of the global prefillable inhaler market in 2018. This segment is projected to grow at a CAGR of 7.0% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to factors such as technological advancements and rising demand for liquid drug pre fillable inhalers from hospital pharmacies and retail pharmacies across regions. Based on application, hospital pharmacies are expected to account for the largest share of the global prefillable inhaler market in 2018 followed by retail pharmacies.
Product Definition:
A prefillable inhaler is a device that can be filled with a dose of medication prior to use. This allows the user to avoid having to measure out the correct dose each time they need it, which can be difficult for some people. The importance of using a prefillable inhaler is that it ensures you are getting the correct dosage each time, which can help improve your treatment plan.
Liquid Drug Prefillable Inhaler:
Liquid drug prefillable inhaler is a prefilled syringe that contains the medication to be inhaled. It's an alternative to the conventional forms of prefilled syringes and vials, which are expected to grow in importance as they help reduce errors during administration and improve patient safety.
The liquid drug formulations can be easily administered by using this device, thereby reducing or eliminating human error from the process.
Powder Prefillable Inhaler:
Powder prefillable inhaler is a device that contains the medication and it's used to dispense the dose. It works by compressed air which is forced through the medicine in powder form. The advantages of this device are that it needs very little maintenance, there’s no risk of overdosing because there’s no need for any kind of measuring devices or capsules and lastly, it saves cost as well as time.
Application Insights:
The market is segmented by application into hospital pharmacy, retail pharmacy, and online pharmacies. The hospital pharmacy held the largest share of the global prefillable inhaler market in 2017 due to factors such as high usage rates and prevalence of chronic respiratory diseases. In addition, an increase in healthcare spending along with a rise in the number of hospitals has led to an increased demand for inhalers which are used for asthma treatment.
The retail pharmacies accounted for a significant share owing to increasing consumer awareness regarding medication adherence supported by government campaigns such as ¢â‚¬Å“Mahanadiagra Maha Sanjay Gandhi Urja Vikas Yojna¢â‚¬ launched by Government of India that encourages people above 60 years age group to take medicine three times daily. This factor is expected to drive growth over the forecast period since consumers prefer purchasing medicines from local stores due these reasons among others.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and high demand for efficient healthcare products are some of the major factors contributing to its growth. Furthermore, increasing government initiatives to create awareness regarding COPD and asthma management is also expected to drive this regional market over the forecast period. For instance, in October 2016 Healthcare providers were encouraged by CDC’s Stop Asthma Mortality Coalition (SAC) to make sure that all patients with asthma receive annual preventive care visits beginning at age 2 years and every year thereafter until they turn 21 years old or until they achieve a clinical diagnosis of asthma between birth & infancy & toddlerhood (stop ASTHMA MORTALITY COALITION).
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with improving healthcare infrastructure especially in developing countries such as India & China.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing rapidly. This is primarily because of the changing lifestyle and environmental conditions. According to the World Health Organization, over 3 billion people suffer from one or more respiratory diseases, out of which, 1.3 billion people are suffering from chronic obstructive pulmonary disease (COPD). Prefillable inhalers provide an effective treatment for these patients and hence, the market for prefillable inhalers is expected to grow rapidly in the coming years.
- Technological advancements: The technology used in prefillable inhalers is constantly evolving with new features being added regularly. This has helped increase their adoption among patients as well as healthcare professionals alike. Some of the latest features that have been included in prefillable inhalers include Bluetooth connectivity, dose tracking capabilities, etc., which make them easier to use and provide better patient outcomes.
Scope Of The Report
Report Attributes
Report Details
Report Title
Prefillable Inhaler Market Research Report
By Type
Liquid Drug Prefillable Inhaler, Powder Prefillable Inhaler, Others
By Application
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
By Companies
Beximco Pharmaceuticals, Heitkamp & Thumann, Midas Care Pharmaceuticals, Cipla, GlaxoSmithKline, M, Biocare Manufacturing, Aristo Pharmaceuticals, Intech Biopharm, Swiss Pharmaceuticals, Gerresheimer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
120
Number of Tables & Figures
84
Customization Available
Yes, the report can be customized as per your need.
Global Prefillable Inhaler Market Report Segments:
The global Prefillable Inhaler market is segmented on the basis of:
Types
Liquid Drug Prefillable Inhaler, Powder Prefillable Inhaler, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Beximco Pharmaceuticals
- Heitkamp & Thumann
- Midas Care Pharmaceuticals
- Cipla
- GlaxoSmithKline
- M
- Biocare Manufacturing
- Aristo Pharmaceuticals
- Intech Biopharm
- Swiss Pharmaceuticals
- Gerresheimer
Highlights of The Prefillable Inhaler Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid Drug Prefillable Inhaler
- Powder Prefillable Inhaler
- Others
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prefillable Inhaler Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A prefillable inhaler is a device that allows people to inhale medication by using a small cartridge filled with the medication. The inhaler can be used to administer medications such as asthma and COPD medications.
Some of the major players in the prefillable inhaler market are Beximco Pharmaceuticals, Heitkamp & Thumann, Midas Care Pharmaceuticals, Cipla, GlaxoSmithKline, M, Biocare Manufacturing, Aristo Pharmaceuticals, Intech Biopharm, Swiss Pharmaceuticals, Gerresheimer.
The prefillable inhaler market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Prefillable Inhaler Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Prefillable Inhaler Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Prefillable Inhaler Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Prefillable Inhaler Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Prefillable Inhaler Market Size & Forecast, 2020-2028
4.5.1 Prefillable Inhaler Market Size and Y-o-Y Growth
4.5.2 Prefillable Inhaler Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Liquid Drug Prefillable Inhaler
5.2.2 Powder Prefillable Inhaler
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Prefillable Inhaler Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Prefillable Inhaler Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Liquid Drug Prefillable Inhaler
9.6.2 Powder Prefillable Inhaler
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 Online Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Liquid Drug Prefillable Inhaler
10.6.2 Powder Prefillable Inhaler
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 Online Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Liquid Drug Prefillable Inhaler
11.6.2 Powder Prefillable Inhaler
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 Online Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Liquid Drug Prefillable Inhaler
12.6.2 Powder Prefillable Inhaler
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 Online Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Liquid Drug Prefillable Inhaler
13.6.2 Powder Prefillable Inhaler
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 Online Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Prefillable Inhaler Market: Competitive Dashboard
14.2 Global Prefillable Inhaler Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Beximco Pharmaceuticals
14.3.2 Heitkamp & Thumann
14.3.3 Midas Care Pharmaceuticals
14.3.4 Cipla
14.3.5 GlaxoSmithKline
14.3.6 M
14.3.7 Biocare Manufacturing
14.3.8 Aristo Pharmaceuticals
14.3.9 Intech Biopharm
14.3.10 Swiss Pharmaceuticals
14.3.11 Gerresheimer
